课题基金 / 基金详情

CLINICAL TRIAL: HUPERZINE A TRIAL

CLINICAL TRIAL: HUPERZINE A TRIAL
临床试验：石杉碱甲试验
批准号：
7724997
负责人：
RUTH MULNARD MCCARGAR
金额：
$0.23万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
2007
资助国家：
美国
项目状态：
已结题
起止时间：
2007-12-01 至 2008-11-30
来源：
https://reporter.nih.gov/project-details/7724997
关键词：
AgingAlzheimer&aposs DiseaseClinical TrialsComputer Retrieval of Information on Scientific Projects DatabaseDoseFundingGrantInstitutesInstitutionPatientsPhase II Clinical TrialsPlacebosPopulationRandomizedResearchResearch PersonnelResourcesSafetySourceUnited States National Institutes of HealthWeekcognitive functionhuperzine A

项目摘要

项目成果

RUTH MULNARD MCCARGAR的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is a Phase II clinical trial supported by the National Institute on Aging and Marco Hi-Tech for a twenty-four week period of exposure in which patients with Alzheimer's disease are randomized to receive escalating doses of Huperzine A versus placebo to evaluate the safety, tolerability, and impact on cognitive function of this agent in this population.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED TRIAL OF THE EFFECTS OF DOCOSAHEXAE
MULTI-CENTER TRIAL TO EVALUATE HOME-BASED ASSESSMENT METHODS FOR ALZHEIMER DISEA
A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED TRIAL OF THE EFFECTS OF DOCOSAHEXAE
CLINICAL TRIAL: ESTROGEN PREVENTION TRIAL